WASHINGTON--(BUSINESS WIRE)--The Melanoma Research Alliance (“MRA”) today announced $5.2 million in grants to support six multidisciplinary teams pursuing innovative, translational research approaches designed to benefit melanoma patients. MRA is a non-profit organization that supports novel research programs worldwide that will advance scientific understanding of melanoma needed to enable the development of better prevention, diagnosis, and treatment approaches. In completing this third grant c
For more information, please visit
http://www.businesswire.com/news/home/20100820005405/en